Maturity-onset diabetes of the young (MODY): an update
The DOI matches its Crossref record; 114 of the 118 references it cites were found in a registry or an index.
Abstract
Maturity-onset diabetes of the young (MODY) is a group of monogenic disorders characterized by autosomal dominantly inherited non-insulin dependent form of diabetes classically presenting in adolescence or young adults before the age of 25 years. MODY is a rare cause of diabetes (1% of all cases) and is frequently misdiagnosed as Type 1 diabetes (T1DM) or Type 2 diabetes (T2DM). A precise molecular diagnosis is essential because it leads to optimal treatment of the patients and allows early diagnosis for their asymptomatic family members. Mutations in the glucokinase (GCK) (MODY 2) and hepatocyte nuclear factor (HNF)1A/4A (MODY 3 and MODY 1) genes are the most common causes of MODY. GCK mutations cause a mild, asymptomatic, and stable fasting hyperglycemia usually requiring no specific treatment. However, mutations in the HNF1A and HNF4A cause a progressive pancreatic β-cell dysfunction and hyperglycemia that can result in microvascular complications. Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin therapy may be required later in life. Mutations in the HNF1B (MODY 5) is associated with pancreatic agenesis, renal abnormalities, genital tract malformations, and liver dysfunction. Compared to MODY 1, 2, 3, and 5, the remaining subtypes of MODY have a much lower prevalence. In this review, we summarize the main clinical and laboratory characteristics of the common and rarer causes of MODY.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risks of microvascular and macrovascular complications with HNF1A-MODY and HNF4AMODY are similar to those observed in people with type 1 and type 2 diabetes (175,176).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [176]
Citations
Cites
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 2×
“The decrease in GCK activity in pancreatic β-cells caused by GCK mutations lead to decreased glucose phosphorylation and glucose sensitivity in β-cells, and a shift in the dose-response relationship between plasma glucose concentrations and insulin secretion to the right (21).”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607 · cited 4×
“A correct diagnosis and differentiating MODY from T1DM and T2DM are important when deciding on a patient’s treatment and determining his or her prognosis, as well as detecting at-risk family members (31, 82, 83).”
BackgroundInfluentialOsbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
Tattersall, R. B., Fajans, S. S., & Arbor, A. (1975) · Diabetes · doi:10.2337/diab.24.1.44 · Cited by 475
Pearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427
Stoffel, M., & Duncan, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13209 · Cited by 406
Research works printed but not linked: 93
- McDonald, 2011, High - sensitivity CRP discriminates from other subtypes of diabetes, Diabetes Care, 10.2337/dc11-0323 · DOI · Paper page
- Spyer, 2001, AT KM Influence of maternal and fetal glucokinase mutations in gestational diabetes, Am J Obstet Gynecol, 185
- Hattersley, 1998, AT Maturity - onset diabetes of the young : clinical heterogeneity explained by genetic heterogeneity, Med, 15, 15
- Chakera, 2012, Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment, Diabetes Care, 10.2337/dc12-0151 · DOI
- Borowiec, 2009, Mutations at the BLK locus linked to maturity onset diabetes of the young and beta - cell dysfunction, Proc Natl Acad Sci USA, 106
- Fajans, 1993, MB Administration of sulfonylureas can increase glucose - induced insulin secretion for decades in patients with maturity - onset diabetes of the young, Diabetes Care, 16, 10.2337/diacare.16.9.1254 · DOI · Paper page
- Colom, 2010, Maturity onset diabetes of the young and pregnancy, Pract Res Clin Endocrinol Metab, 24, 605, 10.1016/j.beem.2010.05.008 · DOI
- Cerf, 2006, ME factors regulating beta function, Transcription cell Eur J Endocrinol, 155
- Schober, 2009, Phenotypical aspects of maturity - onset diabetes of the young diabetes in comparison with Type diabetes mellitus DM in children and adolescents : experience from a large multicentre database, Med, 26, 466
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Molven, 2011, PR Role of molecular genetics in transforming diagnosis of diabetes mellitus, Expert Rev Mol Diagn, 11, 313, 10.1586/erm.10.123 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Massa, 2001, High prevalence of glucokinase mutations in Italian children with MODY Influence on glucose tolerance first - phase insulin response insulin sensitivity and BMI, Diabetologia, 898
- Pearson, 2004, Contrasting diabetes phenotypes associated with hepatocyte nuclear factor alpha and beta mutations, Diabetes Care, 27, 1, 10.2337/diacare.27.5.1102 · DOI · Paper page
- Owen, 2002, AT Heterogeneity in young adult onset diabetes : aetiology alters clinical characteristics, Med, 19, 758
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Chen, 2010, Systematic review of anomalies in renal cysts and diabetes syndrome / maturity onset diabetes of the young type, Med Engl, 123
- Urbanova, 2013, Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity - onset diabetes of the young ? The case of autoimmunity - associated destruction of pancreatic beta - cells in a family of HNF MODY subjects, Int Arch Allergy, 1
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Pontoglio, 2000, alpha controls renal glucose reabsorption in mouse and man, EMBO Rep, 1
- Osbak, 2009, Update on mutations in glucokinase which cause maturity - onset diabetes of the young permanent neonatal diabetes and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 10.1002/humu.21110 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Naylor, 2011, Who should have genetic testing for maturity - onset diabetes of the young, Clin Endocrinol, 422, 10.1111/j.1365-2265.2011.04049.x · DOI
- Borg, 2002, Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune Type diabetes in children older than yr of age, Pediatr Diabetes, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Plengvidhya, 2007, mutations in Thais with maturity onset diabetes of the young, J Clin Endocrinol Metab, 2821, 10.1210/jc.2006-1927 · DOI · Paper page
- Fajans, 2010, and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the mutation Pro fsX, Obesity Transl Res, 63, 1
- Feigerlova, 2006, Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents, Eur J Pediatr, 165
- Kropff, 2011, Prevalence of monogenic diabetes in young adults : a community - based cross - sectional study in Oxfordshire UK, Diabetologia, 10.1007/s00125-011-2090-z · DOI
- Vaxillaire, 2012, The lessons of early - onset monogenic diabetes for the understanding of diabetes pathogenesis, Pract Res Clin Endocrinol Metab, 26, 171, 10.1016/j.beem.2011.12.001 · DOI
- Pearson, 2003, Genetic cause of hyperglycaemia and response to treatment in diabetes, Lancet, 362
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Tattersall, 1975, SS difference between the inheritance of classical juvenile - onset and maturity - onset type diabetes of young people, Diabetes, 24
- Raile, 2011, caused by insulin gene INS deletion clinical characteristics of homozygous and heterozygous individuals, Diabetes Eur J Endocrinol, 165
- McDonald, 2011, Islet autoantibodies can discriminate maturity - onset diabetes of the young from Type diabetes, Med, 28, 1
- Frayling, 1997, Mutations in the hepatocyte nuclear factor - alpha gene are a common cause of maturity - onset diabetes of the young in the, Diabetes, 1
- Pearson, 2007, and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the gene, PLoS Med, 10.1371/journal.pmed.0040118 · DOI · Paper page
- Pearson, 2005, Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor alpha mutations in a large European collection, Diabetologia, 4
- McDonald, 2013, Maturity onset diabetes of the young identification diagnosis, Ann Clin Biochem, 15, 403, 10.1177/0004563213483458 · DOI · Paper page
- MODY, 1995, Ledermann HM Maturity - onset diabetes of the young at least ten times more common in Europe than previously assumed, Diabetologia
- Harries, 2006, AT of the TCF gene encoding hepatocyte nuclear factor - alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes, Hum Mol Genet, 15, 1, 10.1093/hmg/ddl147 · DOI · Paper page
- Tattersall, 1974, Mild familial diabetes with dominant inheritance, J Med, 339
- Schwitzgebel, 2003, Agenesis of human pancreas due to decreased half - life of insulin promoter factor, J Clin Endocrinol Metab, 1
- Sera, 2000, Kawasaki Identification and functional analysis of mutations in the hepatocyte nuclear factor - alpha gene in anti - islet autoantibody - negative Japanese patients with Type diabetes, J Clin Endocrinol Metab, 1
- Bingham, 2001, Mutations in the hepatocyte nuclear factor beta gene are associated with familial hypoplastic glomerulocystic kidney disease, Am J Hum Genet, 24, 1
- Stride, 2002, The genetic abnormality in the beta cell determines the response to an oral glucose load, Diabetologia, 427, 10.1007/s00125-001-0770-9 · DOI · Paper page
- Lambert, 2003, Identifying hepatic nuclear factor alpha mutations in children and young adults with a clinical diagnosis of Type diabetes, Diabetes Care, 26, 1, 10.2337/diacare.26.2.333 · DOI · Paper page
- Edghill, 2006, AT Mutations in hepatocyte nuclear factor beta and their related phenotypes, J Med Genet, 1
- Bowden, 2008, Triple diabetes : coexistence of Type diabetes mellitus and a novel mutation in the gene responsible for MODY in an overweight adolescent, Pediatr Diabetes, 1
- Tuomi, 2006, Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity - onset diabetes of the young type, Diabetes Care, 29, 189, 10.2337/diacare.29.02.06.dc05-1314 · DOI · Paper page
- Habener, 2005, transcriptional regulation in pancreatic development, Endocrinology, 146
- Leslie, 1999, GAD in Type insulin dependent diabetes, Diabetologia, 42, 10.1007/s001250051105 · DOI · Paper page
- Cuesta, 2010, Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene, Diabetes Care, 290, 10.2337/dc09-0681 · DOI
- Shepherd, 2009, AT genetic diagnosis of diabetes alters treatment and improves glycaemic control in the majority of insulin - treated patients, Med, 26, 1
- Velho, 1997, Identification of new glucokinase mutations and description of the clinical profile of families, Diabetologia, 14, 217, 10.1007/s001250050666 · DOI · Paper page
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Steele, 2013, Use of in the identification of patients with hyperglycaemia caused by a glucokinase mutation : observational case control studies One, AM, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Boesgaard, 2010, Further evidence that mutations in INS can be a rare cause of maturity - onset diabetes of the young, BMC Med Genet, 11
- Besser, 2011, RE Urinary - peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor alpha hepatocyte nuclear factor alpha maturity - onset diabetes of the young from long - duration Type diabetes, Diabetes Care, 1
- Colclough, 2013, Mutations in the genes encoding the transcription factors hepatocyte nuclear factor alpha alpha in maturity - onset diabetes of the young and hyperinsulinemic hypoglycemia, Hum Mutat, 1
- Molven, 2008, Mutations in the insulin gene can cause MODY and autoantibody - negative Type diabetes, Diabetes, 1
- Fajans, 2001, SS GI Molecular mechanisms and clinical pathophysiology of maturity - onset diabetes of the young, New Engl J Med, 345
- Edghill, 2006, Hepatocyte nuclear factor beta mutations cause neonatal diabetes and intrauterine growth retardation : support for a critical role of HNF beta in human pancreatic development, Med, 23, 1
- Ulinski, 2006, Renal phenotypes related to hepatocyte nuclear factor beta mutations in a pediatric cohort, J Am Soc Nephrol, 17, 497, 10.1681/asn.2005101040 · DOI · Paper page
- Galan, 2011, Differential effects of HNF alpha mutations associated with familial young - onset diabetes on target gene regulation, Mol Med, 17, 1, 10.2119/molmed.2010.00097 · DOI · Paper page
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Rubio, 2010, Homozygous mutations in are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities, Diabetes, 31, 1
- Neve, 2005, Role of transcription factor and its diabetes - associated gene variants in pancreatic beta cell function, Proc Natl Acad Sci USA, 11, 4807, 10.1073/pnas.0409177102 · DOI · Paper page
- Owen, 2010, Assessment of high - sensitivity reactive protein levels as diagnostic discriminator of maturity - onset diabetes of the young due to mutations, Diabetes Care, 24, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Lehto, 1999, Mutation in the HNF alpha gene affects insulin secretion and triglyceride metabolism, Diabetes, 5, 423, 10.2337/diabetes.48.2.423 · DOI
- Raeder, 2006, PI IS Mas Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction, Nat Genet, 38
- Stride, 2014, Cross - sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia, Diabetologia, 57, 54, 10.1007/s00125-013-3075-x · DOI · Paper page
- Owen, 2003, AT Adolescent onset Type diabetes in a non - obese Caucasian patient with an unbalanced translocation, Med, 20, 483
- Owen, 2011, Thanabalasingham Diagnosis and management of maturity onset diabetes of the young, Brit Med J, 343
- Stoffel, 1997, The maturity - onset diabetes of the young transcription factor alpha regulates expression of genes required for glucose transport and metabolism, Proc Natl Acad Sci USA, 14, 1
- Fajans, 2011, GI genetics pathophysiology clinical decision making, history Diabetes Care, 10.2337/dc11-0035 · DOI · Paper page
- Meur, 2010, Insulin gene mutations resulting in early - onset diabetes : marked differences in clinical presentation metabolic status and pathogenic effect through endoplasmic reticulum retention, Diabetes, 59
- Pihoker, 2013, Prevalence characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in glucokinase : results from the SEARCH for Diabetes in Youth, J Clin Endocrinol Metab, 1
- Horikawa, 1997, Mutation in hepatocyte nuclear factor beta gene associated with, Nat Genet, 17, 384, 10.1038/ng1297-384 · DOI · Paper page
- Martin, 2008, Long - term follow - up of oral glucose tolerance test - derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations, Diabetes Care, 31, 10.2337/dc07-2017 · DOI
- Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young - onset diabetes, Diabetologia, 10.1007/s00125-011-2418-8 · DOI · Paper page
- Docena, 2014, KM novel mutation and the utility of glucagon - like peptide receptor agonist therapy, Endocr Pract, 20, 1, 10.4158/ep13254.or · DOI
- Moller, 1998, Mutations in the hepatocyte nuclear factor - alpha gene in Caucasian families originally classified as having Type I diabetes, AM Diabetologia, 31, 1
- Slingerland, 2006, AS diabetes in children and young adults : challenges for researcher clinician patient, Rev, 171
- Dukes, 1998, ID Defective pancreatic beta - cell glycolytic signaling in hepatocyte nuclear factor alpha - deficient mice, J Biol Chem, 1
- Steele, 2010, AT Increased all - cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the gene, AM Med, 27, 1
- Igarashi, 2005, Roles of beta in kidney development and congenital cystic diseases, Kidney Int, 1
- Gonsorcikova, 2008, Autosomal inheritance of diabetes in two families characterized by obesity and a novel mutation in, Pediatr Diabetes, 241
Cited by
Items 201–246 of 246
A Case Report of a New Locus of Maturity-Onset Diabetes of the Young Type 3 (MODY3)
邝, 楠. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281072
4: Diabetes in Diseases of the Exocrine Pancreas
Abramowitz, J. D., Gunasekaran, U., Samaropoulos, X. F., Tumyan, A., & Lingvay, I. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.ch04
Quilichini, E. (2017) · theses.fr (ABES) · doi:10.70675/5c2d9beaz74c5z4a71z80b0zabce84fcefbc
Đái tháo đường khởi phát ở người trẻ tuổi thể 12 (MODY12): Đặc điểm lâm sàng và điều trị
Lan, N. H., & Ngọc, C. T. B. (2025) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v191i6.3519
Maurin, L. (2024) · theses.fr (ABES) · doi:10.70675/bdd8c28bzecbaz4b2az99cdz98131319a267
Étude des effets de l'hippurate et de ses cibles sur la biologie des cellules bêta et hépatiques
Deslande, M. (2024) · theses.fr (ABES) · doi:10.70675/65318bb4zba06z40c3za36aze387c87034be
Multicellular regulation of the pancreatic islet in diabetes
Fine, N. H. F. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham)
Unravelling the modulation of tight junctions: Molecular mechanisms and permeation enhancement
Brunner, J. (2022) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:161111
DIABETES, E AGORA? ETIOLOGIA DA DOENÇA E FORMAS DE DIAGNÓSTICO: UMA REVISÃO DE LITERATURA
Bisinoto, L. D. L., Guimarães, L. R., & Queiroz, L. E. N. (2026) · Revista Saberes da Fapan
Examining the role of Myt3 in beta-cell function and survival
Tennant, B. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0221439
Diabetes Mody Tipos 2 e 3: uma revisão de literatura
REZENDE, M. L. P., & Tedesco, E. L. (2024) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv16n12-080
BLK Gene Mutation with Maturity Onset Diabetes of Young 11: First Case Report from Karnataka, India
Kumar, R. A., & Sidri, A. (2026) · Archives of Endocrinology and Disorders · doi:10.46889/aed.2026.2202
Hussain, Y., Rauf, M., Khan, A. A., Uppal, R., Uppal, M. R., & Wahab, M. U. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5374488
Health benefits of pistachio consumption in pre-diabetic subjects
Hernández Alonso, P. (2016) · Rovira & Virgili repository
Trouble des conduites alimentaires et diabète en concomitance : étiologie, évaluation et traitement
Gagnon, C. (2018) · Archipel (Université du Québec à Montréal) · Cited by 1
Toluay, E. (2021) · Unipub UB Graz (Universität Graz)
Mahaldar, Y., Musale, H., Mhatre, K., More, A., Mali, B., & Pawar, K. (2026) · International Journal of Pharmaceutical Research and Development · doi:10.33545/26646862.2026.v8.i6a.369
Lendinez-Tortajada, V. (2019) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Budden, F. M. (2022) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-8944
Ptáčková, V. (2019) · Digital library - University of Pardubice (University of Pardubice)
Utility of next-generation sequencing for the genetic study of MODY diabetes
García, M. E., Sarabia-Meseguer, M. D., Martínez, A. M. H., Alonso, A. A., López, M. F., Botía, G. A. M., Gómez, M. F. I., Kyriakos, G., López, A. H., Moreno, A. M. C., et al. (2026) · Journal of Endocrinology · doi:10.1530/joe-25-0344
Newly uncovered novel properties of heparanase in the heart and pancreas
Zhang, D. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0340611
Renin-angiotensin system blockade to prevent preeclampsia in a rodent model of diabetic nephropathy
Marilou, L. (2018) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Aldh1b1-mediated metabolism regulates pancreas progenitor differentiation and β-cell maturation
Rödiger, M. (2023) · Qucosa (Saxon State and University Library Dresden)
Le rôle d’IGFBP2 dans la dysfonction podocytaire et le développement de la néphropathie diabétique
Dancosst, D.-A. (2021) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
MORPHOLOGICAL AND MORPHOMETRIC CHANGES OBSERVED IN THE THYMUS IN DIABETIC PATIENTS
S., N. B., & A., A. Z. (2024) · Web of Medicine: Journal of Medicine, Practice and Nursing
MacIntosh, A. (2016) · Mspace (University of Manitoba)
Ejercicio físico en sujetos prediabéticos : Revisión bibliográfica y propuesta de intervención
Martín, P. R. S. (2021) · Academica-e (Universidad Pública de Navarra)
Stankutė, I. (2022) · Lithuanian University of Health Sciences
Quando l’iperglicemia non è né diabete di tipo 1 né di tipo 2: Il MODY nella pratica clinica
Costantini, S., Contreas, G., Barbetti, F., & Maffeis, C. (2016) · Cineca Institutional Research Information System (Tor Vergata University)
Perfil clínico e laboratorial de crianças com suspeita de diabetes monogênico
Barszcz, K., Luciano, T. M., Arrais, R. F., & Junior, R. D. R. L. (2025) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2025.217049
FAREED, F. M. A. F. (2018) · Yildiz Technical University - AVESIS
Alwatban, S., Alfaraidi, H., Alosaimi, A., Alluhaydan, I., Alfadhel, M., Polak, M., & Almutair, A. (2022) · doi:10.3389/fendo.2021.742278.s001
Rampisela, R. R., Suhartono, R., & Kekalih, A. (2026) · Eduvest - Journal Of Universal Studies · doi:10.59188/eduvest.v6i5.52689
Genetic Basis of Metabolic Evolution in the Cave Fish Astyanax Mexicanus
Aspiras, A. C. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Xia, P., Chen, J., Liu, Y., Cui, X., Wang, C., Zong, S., Wang, L., & Lu, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1550476/v1
Ghosh, K. (2023) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2023.19.002574
Maturity-onset diabetes of the young (MODY): Pathophysiology and dietary management
Das, S. S., Ckakrabarty, G., Chakraborty, S., & Chatterjee, D. (2025) · Journal of Current Research in Food Science · doi:10.22271/foodsci.2025.v6.i1c.200
ĐÁI THÁO ĐƯỜNG CÓ BIẾN THỂ GLY574SER CỦA GEN HNF1A MÃ HÓA CHO YẾU TỐ PHIÊN MÃ HNF-1A
Ngọc, C. T. B., & Ngọc, K. N. (2025) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v550i2.14280
Literature review: Maturity Onset Diabetes of the Young (MODY)
Bramantyo, R., Fauzan, N. R., Wahyudi, R. R., Dzulilmi, D., Putri, S. R. S. D., Prameswari, D. S., Dhevi, N. M. S. G., Putri, A. S., Maudina, B. Z., Rizqi, A. S., et al. (2025) · JURNAL BIOLOGI TROPIS · doi:10.29303/jbt.v25i4.8362
Mohapatra, L., Jena, S., & Samal, J. (2025) · Journal of Emerging Technologies and Innovative Research · doi:10.56975/jetir.v12i11.572291
Insuliini autoantikehade määramine lutsiferaasimmunopretsipitatsioon analüüsimeetodiga
Hellaste, K.-A. (2020) · DSpace repository (University of Tartu)
Application of NGS to molecular diagnosis of maturity-onset diabetes of the young (MODY)
Rodríguez-Fernández, S. (2016) · RUC (Universidade Da Coruña)
Early diagnosis of glomerular damage in pregnant women with diabetes: pilot study
Rodrigue, J. (2019) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Kheriji, N., Dallali, H., Gouiza, I., Hechmi, M., Mahjoub, F., Mrad, M., Krir, A., Soltani, M., Trabelsi, H., Hamdi, W., et al. (2023) · doi:10.3389/fgene.2023.1224284.s002
Metadata
- Authors
- Anık, A., Çatlı, G., Abacı, A., & Böber, E.
- Affiliations
- Dokuz Eylül University (TR)
- Corresponding author
- Abacı, Ayhan
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 28
- Issue
- 3-4
- Pages
- 251-63
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W1986614590
- Cited by
- 198
- References
- 118
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 36 · 2021: 28 · 2020: 29 · 2019: 25 · 2018: 17 · 2017: 8 · 2016: 7 · 2015: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- maturity-onset diabetes of the young, monogenic diabetes, HNF1A mutations, HNF4A mutations, HNF1B mutations, beta-cell dysfunction, pancreatic agenesis, sulfonylurea therapy, ATP-sensitive potassium channels, molecular diagnosis, fasting hyperglycemia, microvascular complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Glucokinase, Humans, Mutation, Sulfonylurea Compounds, Prevalence, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.